The Effectiveness of Risankizumab as Induction Therapy for Crohn's Disease: Data From the Sicilian Network for Inflammatory Bowel Diseases
PMID: 39460746
Source: Inflamm Bowel Dis
DOI:
10.1093/ibd/izae248
Publication date:
2024-10-26
Year:
2025
Abstract
NULL